Abstract:BackgroundThere are limited studies comparing budesonide inhalation suspension (BIS) with montelukast in real-world settings where treatment adherence and persistency may be suboptimal. This real-world study aims to investigate the control effectiveness of montelukast or BIS as a monotherapy in Chinese children with mild asthma.MethodsData were derived from a retrospective questionnaire-based analysis of 2‒14-year-old children with mild persistent asthma, who received either 500 µg of BIS (n = 153) or 4‒5 mg of montelukast (n = 240) once daily. The indicators of asthma control, the Asthma Control Test (ACT)/Childhood ACT (C-ACT) score, and the asthma-related medical costs were assessed. The differences between the two groups were compared using an unpaired t-test (normally distributed), Mann–Whitney U test (non-normally distributed) or chi-squared test (categorical variables).ResultsMedication compliance in the past 3-month period was better in the montelukast group than in the BIS group (P = 0.042). The montelukast group exhibited better asthma control in the past 4-week period, including lower percentages of asthmatic children with symptoms more than twice a week (P = 0.021), had night waking or night coughing (P = 0.022), or required reliever medication more than twice a week (P < 0.001). The montelukast group had a lower percentage of children with an ACT/C-ACT score ≤ 19 (P = 0.015). Caregivers reported a significantly better exercise tolerance in the children who received montelukast vs. BIS in the past 12 months (P < 0.001). Significantly higher medical expenditures attributable to asthma in the past 12 months were observed in the BIS group vs. montelukast group (P < 0.001).ConclusionBoth treatments provided acceptable overall asthma control in children with mild persistent asthma; however, more reliever medication and more medical expenditures attributable to asthma were needed for BIS vs. montelukast in real-world settings, where factors such as compliance were also taken into account.

Investigation and Analysis of Montelukast Sodium Application in Pediatric Outpatients

Clinical Observation of Montelukast Prevention for Wheezing Infants and Young Children after Brochiolitis

Treatment of Pediatric Mild Persistent Asthma with Low-Dose Budesonide Inhalation Suspension Vs.montelukast in China

Effect of montelukast on the apoptosis of eosinophil in bronchoalveloar lavage fluid

Changes of Eosinophils in Bronchoalveolar Lavage Fluid of Asthma in Children and the Modulation Effect of Montelukast

Pharmacokinetics and Bioequivalence of Two Formulations of Montelukast Sodium Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions

The Efficacy of Montelukast on the Airway Hyperresponsiveness in Children with Asthmatic Bron-chitis

Analysis of Outpatient Off-label Use in the Third Hospital of Peking University

Montelukast: results and prospects for applications in pediatric practice

Clinical Observation of Meng Lu Montelukast Sodium in the Treatment of Bronchiolitis

Leukotriene receptor antagonist in children cough variant asthma

Magnesium Sulfate Combined Montelukast Sodium Clinical Observationon Treatment of Infantile Asthma

Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study

Analysis on Application Rationality of Ambroxol Tablets in 50210 Outpatient Prescriptions from Eye and ENT Hospital of Fudan University

The Characteristic and Difference of Drugs Use between Outpatients and Inpatients of Pediatrics and Rationality Analysis in a Grade Three Hospital

Investigation on the Use of Oral High-risk Tablets in Hospitalized Patients in a Children's Hospital in Shanghai

Prescriptions from Traditional Chinese Medicine Compared with Salbutamol and Montelukast for the Treatment of Pediatric Asthma: a Randomized Controlled Trial

Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China

Comments on Pediatric Out-Patient Prescription

Efficacy of Montelukast Sodium Combined with Conventional Treatment for Allergic Purpura in Children

Rationality discussion of the drug dosage commonly used in children's hospital